Patents by Inventor Raymond Q. Migrino

Raymond Q. Migrino has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220088133
    Abstract: Disclosed herein are compositions comprising nanoliposomes useful for the treatment and prevention of stroke.
    Type: Application
    Filed: September 10, 2021
    Publication date: March 24, 2022
    Inventors: Raymond Q. Migrino, Volkmar Weissig
  • Publication number: 20210315821
    Abstract: Disclosed herein are compositions comprising nanoliposomes useful for the treatment and prevention of cerebrovascular and aging-related degenerative diseases.
    Type: Application
    Filed: August 9, 2019
    Publication date: October 14, 2021
    Inventors: Raymond Q. Migrino, Seth Truran, Nina Karamanova, Volkmar Weissig, Jillian Madine, Hannah Davies
  • Publication number: 20160158381
    Abstract: Generally provided herein are methods, compounds, and compositions described useful for the treatment of light chain amyloidosis and other amyloid protein diseases.
    Type: Application
    Filed: July 17, 2014
    Publication date: June 9, 2016
    Inventors: Raymond Q. MIGRINO, Volkmar WEISSIG, Daniel A. FRANCO, Seth TRURAN
  • Publication number: 20080260650
    Abstract: The present invention relates to methods for the detection and therapy of inflamed tissue, whereby immune modulators are used to increase the uptake of diagnostic or therapeutic compositions by inflammatory cells.
    Type: Application
    Filed: October 27, 2005
    Publication date: October 23, 2008
    Applicant: THE GENERAL HOSPITAL Corporation
    Inventors: Ahmed Tawakol, Michael R. Hamblin, Raymond Q. Migrino, Jeffrey Gelfand
  • Publication number: 20080193376
    Abstract: The present invention relates to methods for the detection and therapy of active atheromatous plaques, and in particular vulnerable plaques, whereby immune modulators are used to increase the uptake of diagnostic or therapeutic compositions by the inflammatory cells associated with such plaques.
    Type: Application
    Filed: October 28, 2004
    Publication date: August 14, 2008
    Applicant: The General Hospital Corporation
    Inventors: Ahmed Tawakol, Michael R. Hamblin, Raymond Q. Migrino, Jeffrey Gelfand